PR Newswire
2316 Articles
Founded in 1954 by Herbert Muschel and acquired by Cision in 2015, PR Newswire is the industry’s leading press release distribution partner with a global reach of over 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages.
NUS scientists harness magnetic pulses to reprogram immune cells to fight breast cancer
An innovative approach for breast cancer treatment uses localised and non-invasive pulsed electromagnetic fields to reprogram immune cells, turning them from tumour helpers to cancer killers SINGAPORE, Sept. 14, 2026 /PRNewswire/ -- Researchers from the National University of Singapore (NUS) have d...
Mon, Sep 14
Tomonari Abe, President of Abe Yoando Pharma, Selected as First Japanese Speaker at Longevity Investors Conference 2026 in Switzerland
- Head of 295-year-old Japanese Pharmaceutical Pioneer to Present Asia's Longevity Growth Strategies and Bioscientific Research Initiatives at Prestigious Conference - TOKYO and GSTAAD, Switzerland, Sept. 14, 2026 /PRNewswire/ -- Abe Yoando Pharma Co., Ltd., a nearly 300-year-old pharmaceutical...
Mon, Sep 14
Thunes Launches Cross-Border Payouts Across Six New Middle East Markets
Members of Thunes' Direct Global Network gain faster, more transparent access to bank accounts, mobile wallets, and cash pickup locations across Bahrain, Lebanon, Oman, South Yemen, Syria and the UAE RIYADH, Saudi Arabia, Sept. 14, 2026 /PRNewswire/ --Thunes, the Smart Superhighway to move mone...
Mon, Sep 14
Antengene Publishes Preclinical Research Paper on CD73 Small Molecule Inhibitor ATG-037 Combined with Selinexor in Cancer Gene Therapy
SHANGHAI and HONG KONG, Sept. 14, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimm...
Mon, Sep 14
Solidion Technology Announces Stock Buyback Program
Board Authorization Reflects Confidence in Solidion's Long-Term Strategy and Commitment to Enhancing Shareholder Value DALLAS, Sept. 14, 2026 /PRNewswire/ -- Solidion Technology, Inc.(NASDAQ: STI) ("Solidion Technology" or "the Company"), an advanced battery technology solutions...
Mon, Sep 14
Sorbent to acquire Kenvue's Stayfree and Carefree business in Australia and New Zealand
MELBOURNE, Australia, Sept. 14, 2026 /PRNewswire/ -- Sorbent Paper Company Pty Ltd ("Sorbent") has signed an agreement with Kenvue's Singaporean subsidiary to acquire its Stayfree and Carefree feminine care business in Australia and New Zealand. Following completion of the transaction, t...
Mon, Sep 14
Trina Storage and AMP-lify Sign MoU for 1 GWh of Grid-Connected Battery Storage Projects in Japan
CHUZHOU, China, Sept. 14, 2026 /PRNewswire/ -- Trina Storage, the energy storage business unit of Trinasolar, has signed a Memorandum of Understanding (MoU) with AMP-lify, a Japanese clean energy platform, to supply approximately 1 GWh of grid-connected battery energy storage system (BESS) equipment...
Mon, Sep 14
LINC Expands into Japan with Establishment of LINC K.K.
New joint venture establishes LINC's operating presence in Japan SINGAPORE, Sept. 14, 2026 /PRNewswire/ --On September 11, 2026,LINC, the publisher licensing network operated by IntentBridges Pte. Ltd., has expanded into Japan through the establishment of LINC K.K., a joint venture between Sing...
Mon, Sep 14
'99 Quna Festival' Wraps Up as Qunabox's Physical AI Entertainment Debut Draws Crowds, Giving Its Second Growth Curve Early Market Validation
SHANGHAI, Sept. 14, 2026 /PRNewswire/ -- Qunabox Group's "99 Quna Festival" drew to a close on the evening of Sept. 13, when the last AI interactive terminal in Shanghai shut down its experience channel for the day. Over the five-day event, the focus fell not only on the group's alre...
Mon, Sep 14
Accro Bioscience Announces Inclusion of AC-101 tablets in the NMPA CDE's "Caring Plan-Extension" Pilot Program for Rare Disease Drug Development
NEW YORK and SUZHOU, China, Sept. 14, 2026 /PRNewswire/ -- On September 14, 2026 (China Standard Time, UTC+8), Accro Bioscience announced that AC-101 tablets have been included in the Rare Diseases Innovative Drug Development Encouragement Pilot Program (the "Caring Plan-Extension", known in...
Mon, Sep 14
Singapore to Host Shared Services Leaders at 29th Asian Shared Services & Outsourcing Week 2026 This October
Join Asia's shared services and GBS community for AI insights, sponsor-led sessions and networking, 20–23 October 2026. SINGAPORE, Sept. 14, 2026 /PRNewswire/ -- With five weeks to go, the 29th Asian Shared Services & Outsourcing Week (SSOW) will bring shared services and Global Business Se...
Mon, Sep 14
Qupital Raises $300M in Series C Led by M Capital and New MUFG ABS Financing, Eyes Overseas Markets and IPO
Sustained profitability, industry leading performance, and tech driven automation position Hong Kong's digital trade finance leader for its next phase of expansion. HONG KONG, Sept. 13, 2026 /PRNewswire/ -- Qupital, Asia's leading AI-driven fintech platform specializing in cross border e-co...
Mon, Sep 14
Auria Announces Partnership and Contract with Mitsubishi Electric to Advance Next-Generation SATCOM Mission and Resource Management
COLORADO SPRINGS, Colo., Sept. 14, 2026 /PRNewswire/ -- Auria, a leading provider of advanced space, missile, and cyber solutions, today announced a partnership and contract with Mitsubishi Electric Corporationto deliver next-generation satellite communications capabilities through Auria's advan...
Mon, Sep 14
Philippine Seven Corporation Selects RELEX to Improve Forecasting
7-Eleven Philippines becomes the latest retailer to join RELEX's global customer network MANDALUYONG CITY, Philippines, Sept. 14, 2026 /PRNewswire/ -- Philippine Seven Corporation(PSC), the exclusive operator of 7-Eleven convenience stores in the Philippines, is now utilizing forecasting and re...
Mon, Sep 14
Meritz Securities Connects to Bruce Markets' Data Feed for U.S. Equities, Improving Market Data for Korean Traders
Demand for multi-venue competition grows in South Korea to prevent 'blind trading' during U.S. overnight session CHICAGO and SEOUL, South Korea, Sept. 14, 2026 /PRNewswire/ -- Bruce Markets, which operates the overnight U.S. equities trading venue Bruce ATS, today announced that Meritz Sec...
Sun, Sep 13
CPO Design Evolution Drives Gen Precision's Expansion of Custom FAU Inspection for Production Lines
Gen Precision expands the GTK-OSI1 for production-line inspection of FAUs with up to 80 channels and custom structures, delivering 3σ ≤ 0.1 μm repeatability. TAOYUAN, Sept. 14, 2026 /PRNewswire/ -- Gen Precision is expanding its inspection capabilities for co-packaged optics (CPO) applications as m...
Sun, Sep 13
FDA Approves Telix's Brain Cancer Imaging Drug Pixclara
Pixclara® is the first FDA-approved FET-PET imaging drug for glioma (brain cancer). Approval addresses a significant unmet need, helping physicians to differentiate recurrent or progressive glioma from treatment-related change in adults and pediatric patients. FET-PET imaging is recommended in i...
Sun, Sep 13
IonOpticks launches Aurora Series® 5 and new CoreJet™ emitter technology, advancing robust nano-LC for routine proteomics research.
New CoreJet™ integrated emitter technology and a redesigned nanoZero® union combine proven Aurora Series® performance with a step-change in robustness, lowering cost per sample without compromising the depth and sensitivity researchers depend on. MELBOURNE, Australia, Sept. 14, 2026 /PRNewswire/ --...
Sun, Sep 13
SUNMI Deepens Eurasia Partnership at the Belt and Road Summit
HONG KONG, Sept. 13, 2026 /PRNewswire/ -- SUNMI Technology (06810.HK) announced on September 10, separate cooperation agreements with Türkiye-based fintech company TOKEN and Mongolia-based digital bank M bank at the 11th Belt and Road Summit in Hong Kong. The agreements will bring together SUNMI&...
Sun, Sep 13
Ivonescimab Versus Pembrolizumab in First-Line PD-L1-Positive NSCLC: Positive Overall Survival Results from HARMONi-2 Presented at WCLC 2026
HONG KONG, Sept. 13, 2026 /PRNewswire/ --Akeso, Inc. (9926.HK) today announced the presentation of positive overall survival (OS) results from the randomized, double-blind, multicenter, registrational Phase III HARMONi-2 study (AK112-303) at the 2026 World Conference on Lung Cancer (WCLC), organized...
Sun, Sep 13
